ASHI Journal Club #5 - HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity. Evidence for the alloimmune basis and prognostic significance of borderline T cell–mediated rejection.
Chris Wiebe, MD, FRCPC Nephrologist University of Manitoba Canadian Blood Services
Annette M. Jackson, PhD, D(ABHI) Associate Professor, Department of Surgery Chief, Clinical Transplantation Immunology Research Director, Clinical Transplantation Immunology Laboratory Duke University
September 16, 2020
Has Certificate: